The Use of Advanced Cardiac MRI in Heart Failure and Cardiac Hypertrophy

Posted On 2020-07-03 08:40:56


This series on “The Use of Advanced Cardiac MRI in Heart Failure and Cardiac Hypertrophy” is edited by Andrew J. M. Lewis and Oliver J. Rider from Radcliffe Department of Medicine, University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford, UK.

Cardiovascular magnetic resonance (CMR) provides an exquisite anatomical and functional assessment of the heart and vascular system and does so without the use of ionizing radiation. Through the development of an array of specialised and complementary imaging sequences, clinical CMR has now become a “one-stop shop” for diagnostic and prognostic imaging to answer a wide range of clinical questions.

Editorial on The Use of Advanced Cardiac MRI in Heart Failure and Cardiac Hypertrophy
Cardiovascular magnetic resonance: at the heart of 21st Century imaging
Andrew J. M. Lewis, Oliver J. Rider

Should everyone have an MRI in heart failure?
Chrysovalantou Nikolaidou, Theodoros Karamitsos

Editorial Commentary on The Use of Advanced Cardiac MRI in Heart Failure and Cardiac Hypertrophy
Should CMR be the default imaging modality in clinical trials for heart failure?
Moritz Hundertmark

Original Article on The Use of Advanced Cardiac MRI in Heart Failure and Cardiac Hypertrophy
Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
Jennifer J. Rayner, Ines Abdesselam, Joanna d’Arcy, Saul G. Myerson, Stefan Neubauer, Hugh Watkins, Vanessa M. Ferreira, Oliver J. Rider

Review Article on The Use of Advanced Cardiac MRI in Heart Failure and Cardiac Hypertrophy
The use of cardiovascular magnetic resonance for the assessment of left ventricular hypertrophy
Andrew J. M. Lewis, Oliver J. Rider

Use of cardiac magnetic resonance to detect changes in metabolism in heart failure
William D. Watson, Jack J. J. Miller, Andrew Lewis, Stefan Neubauer, Damian Tyler, Oliver J. Rider, Ladislav Valkovič

Cardiovascular magnetic resonance imaging for inflammatory heart diseases
Andrew J. M. Lewis, Matthew K. Burrage, Vanessa M. Ferreira

The use of cardiovascular magnetic resonance as an early non-invasive biomarker for cardiotoxicity in cardio-oncology
Matthew K. Burrage, Vanessa M. Ferreira

Non-invasive investigation of myocardial energetics in cardiac disease using 31P magnetic resonance spectroscopy
Mark A. Peterzan, Andrew J. M. Lewis, Stefan Neubauer, Oliver J. Rider